Timber Pharmaceuticals announced that the staff of NYSE Regulation has determined to immediately suspend trading in the company’s common stock from NYSE American as a result of the voluntary bankruptcy petitions filed under Chapter 11 by the company and certain of its subsidiaries on November 17. Trading of the company’s common stock was suspended at the opening of business on November 29. Also on November 29, a Form 25-NSE was filed with the SEC, which will remove the company’s securities from listing and registration on the NYSE American. Once the delisting from the NYSE American takes effect, the company’s common stock is expected to begin trading on the OTC market expected to trade under the symbol “TMBRQ”.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMBR:
- Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
- Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
- Timber Pharmaceuticals Inc trading resumes
- Timber Pharmaceuticals Inc trading halted, news pending
- Timber Pharmaceuticals proposal to approve merger not approved by stockholders
